USA
News & Media
Take a closer look at what we’re doing across Teva worldwide
Press releases
Mar 20 / 2020
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month
Mar 16 / 2020
Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for Injection
HERZUMA is a biosimilar to HERCEPTIN®1 (trastuzumab)
Mar 12 / 2020
Avis favorable de l'Institut national pour l'excellence clinique (NICE) pour le premier traitement anti-PRGC de la migraine : AJOVY®▼ (fremanezumab)
Mar 12 / 2020
Positive Empfehlung des NICE für die erste, gegen das CGRP gerichtete Migränetherapie: AJOVY®▼ (Fremanezumab)
Top Stories
Read the latest Teva news
11/Mar/2020
Teva Update Regarding COVID-19
As the COVID-19 situation evolves globally, Teva strives to provide an uninterrupted supply of medicines for the millions of patients it serves around the world.
What Teva Is Doing to Help Save the Lives of Thousands of Children with Cancer and Blood Disorders in Africa
For International Childhood Cancer Day, we announced Teva’s new donation partnership with Direct Relief and Global HOPE, which will facilitate access to essential medicines in sub-Saharan Africa. Teva will provide medicines to Global HOPE to help treat pediatric cancer and blood disorders in children; Direct Relief will ensure shipping and delivery of the medicines.
